70255-0025 BRAFTOVI - CanMED: NDC

Product NDC:

70255-0025

Brand Name:

BRAFTOVI

Generic Name:

Encorafenib

Dosage Form Name:

CAPSULE

Administration Route:

Oral

Substances:

Name: ENCORAFENIB

Strength: 75.0

Unit: mg/1

Packages:

Code: 70255-0025-01

Description: 2 BOTTLE in 1 CARTON (70255-025-01) / 90 CAPSULE in 1 BOTTLE (70255-025-02)

Effective Date: June 27, 2018

Discontinued:

Code: 70255-0025-03

Description: 2 BOTTLE in 1 CARTON (70255-025-03) / 60 CAPSULE in 1 BOTTLE (70255-025-04)

Effective Date: June 27, 2018

Discontinued:

Code: 70255-0025-05

Description: 90 CAPSULE in 1 BOTTLE (70255-025-05)

Effective Date: Aug. 3, 2020

Discontinued:

Code: 70255-0025-06

Description: 60 CAPSULE in 1 BOTTLE (70255-025-06)

Effective Date: Aug. 3, 2020

Discontinued:

SEER*Rx Category:

Chemotherapy

Major Class:

BRAF Inhibitor

Minor Class:

V600E

Orphan Drug Designation:

Status:

In Use

CanMED and the Oncology Toolbox